Free Trial

Sequent Asset Management LLC Takes $1.02 Million Position in Healthcare Realty Trust Incorporated (NYSE:HR)

Healthcare Realty Trust logo with Finance background

Sequent Asset Management LLC purchased a new stake in shares of Healthcare Realty Trust Incorporated (NYSE:HR - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 60,450 shares of the real estate investment trust's stock, valued at approximately $1,022,000.

A number of other large investors also recently made changes to their positions in the company. Starboard Value LP bought a new position in shares of Healthcare Realty Trust during the fourth quarter valued at about $342,110,000. Rush Island Management LP increased its holdings in Healthcare Realty Trust by 21.2% during the fourth quarter. Rush Island Management LP now owns 15,681,440 shares of the real estate investment trust's stock worth $265,800,000 after buying an additional 2,747,848 shares during the last quarter. Norges Bank purchased a new stake in Healthcare Realty Trust during the fourth quarter worth about $76,825,000. Northern Trust Corp increased its holdings in Healthcare Realty Trust by 40.3% during the fourth quarter. Northern Trust Corp now owns 4,040,969 shares of the real estate investment trust's stock worth $68,494,000 after buying an additional 1,159,763 shares during the last quarter. Finally, Farallon Capital Management LLC increased its holdings in Healthcare Realty Trust by 25.4% during the fourth quarter. Farallon Capital Management LLC now owns 3,264,000 shares of the real estate investment trust's stock worth $55,325,000 after buying an additional 661,000 shares during the last quarter.

Healthcare Realty Trust Price Performance

Shares of HR traded down $0.06 during trading hours on Monday, hitting $15.86. The company's stock had a trading volume of 3,629,148 shares, compared to its average volume of 3,152,317. The company has a market cap of $5.57 billion, a price-to-earnings ratio of -14.55 and a beta of 0.89. The business has a 50 day simple moving average of $15.03 and a two-hundred day simple moving average of $15.95. Healthcare Realty Trust Incorporated has a 52-week low of $14.09 and a 52-week high of $18.90.

Healthcare Realty Trust (NYSE:HR - Get Free Report) last posted its earnings results on Thursday, May 1st. The real estate investment trust reported $0.39 earnings per share for the quarter, hitting the consensus estimate of $0.39. The firm had revenue of $288.86 million during the quarter, compared to the consensus estimate of $297.39 million. Healthcare Realty Trust had a negative net margin of 31.32% and a negative return on equity of 7.06%. The company's revenue was down 9.2% on a year-over-year basis. During the same quarter last year, the company earned $0.39 earnings per share. Research analysts predict that Healthcare Realty Trust Incorporated will post 1.59 earnings per share for the current year.

Healthcare Realty Trust Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, May 23rd. Stockholders of record on Monday, May 12th were given a $0.31 dividend. The ex-dividend date was Monday, May 12th. This represents a $1.24 dividend on an annualized basis and a dividend yield of 7.82%. Healthcare Realty Trust's dividend payout ratio (DPR) is currently -113.76%.

Insider Activity at Healthcare Realty Trust

In other news, Director Thomas N. Bohjalian acquired 2,500 shares of the business's stock in a transaction dated Tuesday, May 13th. The stock was bought at an average cost of $14.71 per share, for a total transaction of $36,775.00. Following the completion of the transaction, the director owned 56,502 shares of the company's stock, valued at $831,144.42. The trade was a 4.63% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.37% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on HR shares. JPMorgan Chase & Co. decreased their price objective on shares of Healthcare Realty Trust from $18.00 to $17.00 and set a "neutral" rating for the company in a report on Thursday, June 26th. Wells Fargo & Company decreased their price objective on shares of Healthcare Realty Trust from $16.00 to $15.00 and set an "underweight" rating for the company in a report on Monday, June 2nd. Wedbush decreased their price objective on shares of Healthcare Realty Trust from $18.00 to $16.00 and set a "neutral" rating for the company in a report on Monday, May 5th. Finally, Wall Street Zen downgraded shares of Healthcare Realty Trust from a "hold" rating to a "sell" rating in a report on Saturday, May 31st. Two investment analysts have rated the stock with a sell rating and four have assigned a hold rating to the stock. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $16.40.

Check Out Our Latest Analysis on HR

About Healthcare Realty Trust

(Free Report)

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.

Recommended Stories

Institutional Ownership by Quarter for Healthcare Realty Trust (NYSE:HR)

Should You Invest $1,000 in Healthcare Realty Trust Right Now?

Before you consider Healthcare Realty Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthcare Realty Trust wasn't on the list.

While Healthcare Realty Trust currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines